The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2020 | Impressive data: zanubrutinib for Waldenström’s macroglobulinemia
Judith Trotman
• 26 May 2020
Judith Trotman, MBChB, FRACP, FRCPA, of the University of Sydney School of Medicine, Sydney, Australia, discusses exciting data in the use of zanubrutinib for Waldenström’s macroglobulinemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
